Reports
Sale
United States Generic Injectables Market Size, Share, Report: By Therapeutic Area: Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular; By Containers: Vials, Ampoules, Premix, Prefilled Syringes, Others; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies; Market Dynamics; Competitive Landscape; 2024-2032
United States Generic Injectables Market Outlook
The United States generic injectables market size reached a value of almost USD 15.07 billion in 2023. The industry is further expected to grow at a CAGR of 7% between 2024 and 2032 to reach a value of almost USD 27.76 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The United States generic injectables market is driven by the extensive use of the product owing to an increase in the lifestyle ailments caused by non-nutritive diet, sedentary lifestyles, and ageing population. The market significantly contributes to the growth of the overall North America generic injectables market, which is the leading regional market on a global scale.
On account of several benefits offered by generic injectables, the government is supporting its manufacturers in the United States. In addition to this, several factors, such as an increase in the drug shortage in the United States, ageing population, rising prevalence of chronic and lifestyle diseases, and patent expiry of a number of blockbuster drugs, are significantly contributing to the market growth.
Properties and Applications
Generic injectables are bioequivalent of branded drugs that are not covered by patents. Their purpose is to rapidly transport the drug into the body, bypassing the first-pass metabolism. On account of their similar quality, strength, effect, dosage, and active ingredient, generic injectables are as effective and safe as innovator injectables. They are used in the treatment of diseases like cancer, diabetes, rheumatoid arthritis, osteoporosis, osteoarthritis, respiratory, and cardiovascular disorders.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is segmented on the basis of the therapeutic area into:
- Oncology
- Anaesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular
On the basis of containers, the industry is divided into:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
- Others
On the basis of the distribution channel, the market is segregated into:
- Retail Pharmacies
- Hospital Pharmacies
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The generic injectables industry in the United States is driven by the increase in the demand for the product owing to increasing investment for the development of generic drugs by the United States government. This will help promote the market and decrease the expenditure on healthcare in the United States. Moreover, shortages of drugs, along with quick approvals by the USFDA, will fuel the manufacturing of these drugs, thereby increasing the market growth. Further, many of the branded injectables firms are expected to lose their patent protection in the coming years, as a result offering enormous lucrative opportunities to the manufacturers of generic injectables.
Competitive Landscape
The report gives a detailed analysis of the following key players in the United States generic injectables market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Pfizer Inc.
- Hikma Pharmaceuticals PLC
- Sandoz International GmbH
- Teligent, Inc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Therapeutic Area |
|
| Breakup by Containers |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 United States
7 Opportunities and Challenges in the Market
8 Global Generic Drug Market Overview
8.1 Key Industry Highlights
8.2 Global Generic Drug Historical Market (2018-2023)
8.3 Global Generic Drug Market Forecast (2024-2032)
8.4 Global Generic Drug Market by Region
8.4.1 North America
8.4.2 Europe
8.4.3 Asia Pacific
8.4.4 Latin America
8.4.5 Middle East and Africa
9 Global Generic Injectables Drug Market Overview
9.1 Key Industry Highlights
9.2 Global Generic Injectables Historical Market (2018-2023)
9.3 Global Generic Injectables Market Forecast (2024-2032)
9.4 Global Generic Injectables Market by Therapeutic Area
9.5 Global Generic Injectables Market by Containers
9.6 Global Generic Injectables Market by Distribution Channel
9.7 Global Generic Injectables Market by Region
9.7.1 North America
9.7.2 Europe
9.7.3 Asia Pacific
9.7.4 Latin America
9.7.5 Middle East and Africa
10 United States Generic Drug Market Overview
10.1 Key Industry Highlights
10.2 United States Generic Drug Historical Market (2018-2023)
10.3 United States Generic Drug Market Forecast (2024-2032)
11 United States Generic Injectables Market Analysis
11.1 Key Industry Highlights
11.2 United States Generic Injectables Historical Market (2018-2023)
11.3 United States Generic Injectables Market Forecast (2024-2032)
11.4 United States Generic Injectables Market by Therapeutic Area
11.4.1 Oncology
11.4.1.1 Historical Trend (2018-2023)
11.4.1.2 Forecast Trend (2024-2032)
11.4.2 Anaesthesia
11.4.2.1 Historical Trend (2018-2023)
11.4.2.2 Forecast Trend (2024-2032)
11.4.3 Anti-Infectives
11.4.3.1 Historical Trend (2018-2023)
11.4.3.2 Forecast Trend (2024-2032)
11.4.4 Parenteral Nutrition
11.4.4.1 Historical Trend (2018-2023)
11.4.4.2 Forecast Trend (2024-2032)
11.4.5 Cardiovascular
11.4.5.1 Historical Trend (2018-2023)
11.4.5.2 Forecast Trend (2024-2032)
11.5 United States Generic Injectables Market by Containers
11.5.1 Vials
11.5.1.1 Historical Trend (2018-2023)
11.5.1.2 Forecast Trend (2024-2032)
11.5.2 Ampoules
11.5.2.1 Historical Trend (2018-2023)
11.5.2.2 Forecast Trend (2024-2032)
11.5.3 Premix
11.5.3.1 Historical Trend (2018-2023)
11.5.3.2 Forecast Trend (2024-2032)
11.5.4 Prefilled Syringes
11.5.4.1 Historical Trend (2018-2023)
11.5.4.2 Forecast Trend (2024-2032)
11.5.5 Others
11.6 United States Generic Injectables Market by Distribution Channel
11.6.1 Retail Pharmacies
11.6.1.1 Historical Trend (2018-2023)
11.6.1.2 Forecast Trend (2024-2032)
11.6.2 Hospital Pharmacies
11.6.2.1 Historical Trend (2018-2023)
11.6.2.2 Forecast Trend (2024-2032)
12 Market Dynamics
12.1 SWOT Analysis
12.1.1 Strengths
12.1.2 Weaknesses
12.1.3 Opportunities
12.1.4 Threats
12.2 Porter’s Five Forces Analysis
12.2.1 Supplier’s Power
12.2.2 Buyers Power
12.2.3 Threat of New Entrants
12.2.4 Degree of Rivalry
12.2.5 Threat of Substitutes
12.3 Key Indicators for Demand
12.4 Key Indicators for Price
13 Value Chain Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Company Profiles
14.2.1 Pfizer Inc.
14.2.1.1 Company Overview
14.2.1.2 Product Portfolio
14.2.1.3 Demographic Reach and Achievements
14.2.1.4 Financial Summary
14.2.1.5 Certifications
14.2.2 Hikma Pharmaceuticals PLC
14.2.2.1 Company Overview
14.2.2.2 Product Portfolio
14.2.2.3 Demographic Reach and Achievements
14.2.2.4 Financial Summary
14.2.2.5 Certifications
14.2.3 Sandoz International GmbH
14.2.3.1 Company Overview
14.2.3.2 Product Portfolio
14.2.3.3 Demographic Reach and Achievements
14.2.3.4 Financial Summary
14.2.3.5 Certifications
14.2.4 Teligent, Inc
14.2.4.1 Company Overview
14.2.4.2 Product Portfolio
14.2.4.3 Demographic Reach and Achievements
14.2.4.4 Financial Summary
14.2.4.5 Certifications
14.2.5 Others
15 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Generic Drug Market: Key Industry Highlights, 2018 and 2032
2. Global Generic Injectables Market: Key Industry Highlights, 2018 and 2032
3. United States Generic Drug Market: Key Industry Highlights, 2018 and 2032
4. United States Generic Injectables Market: Key Industry Highlights, 2018 and 2032
5. United States Generic Injectables Historical Market: Breakup by Therapeutic Area (USD Billion), 2018-2023
6. United States Generic Injectables Market Forecast: Breakup by Therapeutic Area (USD Billion), 2024-2032
7. United States Generic Injectables Historical Market: Breakup by Containers (USD Billion), 2018-2023
8. United States Generic Injectables Market Forecast: Breakup by Containers (USD Billion), 2024-2032
9. United States Generic Injectables Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
10. United States Generic Injectables Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
11. United States Generic Injection Market Structure
Key Questions Answered in the Report
In 2023, the market in the United States attained a value of nearly USD 15.07 billion.
The market is expected to grow at a CAGR of 7% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach around USD 27.76 billion by 2032.
The major drivers of the market are increasing investments into the development of generic drugs by the government and expiration of patent protection in the coming years.
The key trends guiding the growth of the generic injectables market include growing geriatric population and the fast-track approvals by the United States FDA.
The major therapeutic areas of generic injectables in the market are oncology, anaesthesia, anti-infectives, parenteral nutrition, and cardiovascular.
Vials, ampoules, premix, and prefilled syringes, among others, are the various containers of generic injectables in the market.
Retail pharmacies and hospital pharmacies are the leading distribution channels of generic injectables.
The major players in the United States generic injectables market are Pfizer Inc., Hikma Pharmaceuticals PLC, Sandoz International GmbH, and Teligent, Inc, among others.
Analyst Review
The United States generic injectables market attained a value of USD 15.07 billion in 2023 driven by increasing governmental investment into the development of generic drugs. Aided by the expiration of patent protection of various blockbuster drugs in the coming years, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 7%. The industry in the United States is projected to reach USD 27.76 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its therapeutic areas, the industry can be segmented into oncology, anaesthesia, anti-infectives, parenteral nutrition, and cardiovascular. On the basis of containers, the industry is divided into vials, ampoules, premix, prefilled syringes, and others. On the distribution channel, the industry is divided into retail pharmacies and hospital pharmacies. The key players in the above market include Pfizer Inc., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Teligent, Inc, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER